$PHIL
PHI GROUP INC

2024 Q1 Form 10-Q Financial Statement

#000149315224009464 Filed on March 11, 2024

View on sec.gov

Income Statement

Concept 2024 Q1 2023 Q4
Revenue $5.000K
YoY Change
Cost Of Revenue
YoY Change
Gross Profit
YoY Change
Gross Profit Margin
Selling, General & Admin $221.0K $186.7K
YoY Change
% of Gross Profit
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization
YoY Change
% of Gross Profit
Operating Expenses $221.0K $186.7K
YoY Change -28.04% -13.24%
Operating Profit -$221.0K -$181.7K
YoY Change -28.04% -15.56%
Interest Expense $76.92K $236.6K
YoY Change -79.6% 65.75%
% of Operating Profit
Other Income/Expense, Net -$1.469M -$1.530M
YoY Change -0.15% 280.88%
Pretax Income -$1.690M -$1.712M
YoY Change
Income Tax
% Of Pretax Income
Net Earnings -$1.690M -$1.712M
YoY Change -4.96% 177.49%
Net Earnings / Revenue -34238.76%
Basic Earnings Per Share $0.00 $0.00
Diluted Earnings Per Share $0.00 $0.00
COMMON SHARES
Basic Shares Outstanding 46.15B shares 42.71B shares
Diluted Shares Outstanding 44.03B shares 42.68B shares

Balance Sheet

Concept 2024 Q1 2023 Q4
SHORT-TERM ASSETS
Cash & Short-Term Investments $41.75K $29.45K
YoY Change
Cash & Equivalents $41.75K $29.44K
Short-Term Investments $0.00 $10.00
Other Short-Term Assets $83.33K $120.6K
YoY Change -65.62% -73.33%
Inventory
Prepaid Expenses
Receivables
Other Receivables
Total Short-Term Assets $125.1K $150.1K
YoY Change -55.69% -68.18%
LONG-TERM ASSETS
Property, Plant & Equipment
YoY Change
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments $32.40K $33.11K
YoY Change
Other Assets $0.00
YoY Change
Total Long-Term Assets $32.40K $33.11K
YoY Change -13.83% -10.5%
TOTAL ASSETS
Total Short-Term Assets $125.1K $150.1K
Total Long-Term Assets $32.40K $33.11K
Total Assets $157.5K $183.2K
YoY Change -50.77% -63.99%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $621.3K $618.4K
YoY Change 0.95% 1.13%
Accrued Expenses $2.289M $2.346M
YoY Change 81.44% 96.63%
Deferred Revenue $1.030M $1.103M
YoY Change 35.42% 67.01%
Short-Term Debt $3.018M $2.260M
YoY Change 270.59% 137.63%
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $9.094M $8.730M
YoY Change 5.67% 18.12%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00
YoY Change
Other Long-Term Liabilities
YoY Change
Total Long-Term Liabilities $0.00 $0.00
YoY Change
TOTAL LIABILITIES
Total Short-Term Liabilities $9.094M $8.730M
Total Long-Term Liabilities $0.00 $0.00
Total Liabilities $9.094M $8.730M
YoY Change 5.67% 18.12%
SHAREHOLDERS EQUITY
Retained Earnings -$83.71M -$82.02M
YoY Change 10.24% 10.61%
Common Stock $75.69M $74.48M
YoY Change 7.68% 9.68%
Preferred Stock
YoY Change
Treasury Stock (at cost) $44.17K $44.17K
YoY Change 0.0% 0.0%
Treasury Stock Shares
Shareholders Equity -$8.937M -$8.546M
YoY Change
Total Liabilities & Shareholders Equity $157.5K $183.2K
YoY Change -50.77% -63.99%

Cashflow Statement

Concept 2024 Q1 2023 Q4
OPERATING ACTIVITIES
Net Income -$1.690M -$1.712M
YoY Change -4.96% 177.49%
Depreciation, Depletion And Amortization
YoY Change
Cash From Operating Activities -$1.723M -$884.9K
YoY Change
INVESTING ACTIVITIES
Capital Expenditures
YoY Change
Acquisitions
YoY Change
Other Investing Activities $0.00 $0.00
YoY Change
Cash From Investing Activities $0.00 $0.00
YoY Change
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 1.736M 910.6K
YoY Change
NET CHANGE
Cash From Operating Activities -1.723M -884.9K
Cash From Investing Activities 0.000 0.000
Cash From Financing Activities 1.736M 910.6K
Net Change In Cash 12.30K 25.67K
YoY Change
FREE CASH FLOW
Cash From Operating Activities -$1.723M -$884.9K
Capital Expenditures
Free Cash Flow
YoY Change

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
dei Amendment Flag
AmendmentFlag
false
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q2
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--06-30
dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
dei Entity Central Index Key
EntityCentralIndexKey
0000704172
PHIL Cash In Transit
CashInTransit
usd
us-gaap Increase Decrease In Derivative Liabilities
IncreaseDecreaseInDerivativeLiabilities
usd
us-gaap Increase Decrease In Deferred Charges
IncreaseDecreaseInDeferredCharges
usd
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
usd
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
usd
PHIL Increase Decrease In Subfund Obligations And Contingency Commitments
IncreaseDecreaseInSubfundObligationsAndContingencyCommitments
usd
us-gaap Increase Decrease In Contract With Customer Liability
IncreaseDecreaseInContractWithCustomerLiability
usd
us-gaap Payments To Acquire Investments
PaymentsToAcquireInvestments
usd
us-gaap Payments To Acquire Investments
PaymentsToAcquireInvestments
usd
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
usd
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
usd
us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
usd
dei Document Type
DocumentType
10-Q
dei Document Quarterly Report
DocumentQuarterlyReport
true
dei Document Period End Date
DocumentPeriodEndDate
2023-12-31
dei Document Transition Report
DocumentTransitionReport
false
dei Entity File Number
EntityFileNumber
001-38255-NY
dei Entity Registrant Name
EntityRegistrantName
PHI GROUP, INC.
dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
WY
dei Entity Tax Identification Number
EntityTaxIdentificationNumber
90-0114535
dei Entity Address Address Line1
EntityAddressAddressLine1
2323 Main Street
dei Entity Address City Or Town
EntityAddressCityOrTown
Irvine
dei Entity Address State Or Province
EntityAddressStateOrProvince
CA
dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
92614
dei City Area Code
CityAreaCode
714
dei Local Phone Number
LocalPhoneNumber
642-0571
dei Security12b Title
Security12bTitle
Common Stock
dei Trading Symbol
TradingSymbol
PHIL
dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
dei Entity Interactive Data Current
EntityInteractiveDataCurrent
No
dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
dei Entity Small Business
EntitySmallBusiness
true
dei Entity Shell Company
EntityShellCompany
false
CY2024Q1 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
46150489186 shares
CY2023Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
29442 usd
CY2023Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
19765 usd
CY2023Q4 us-gaap Marketable Securities Current
MarketableSecuritiesCurrent
5 usd
CY2023Q2 us-gaap Marketable Securities Current
MarketableSecuritiesCurrent
420 usd
CY2023Q4 us-gaap Other Assets Current
OtherAssetsCurrent
120615 usd
CY2023Q2 us-gaap Other Assets Current
OtherAssetsCurrent
241426 usd
CY2023Q4 us-gaap Assets Current
AssetsCurrent
150063 usd
CY2023Q2 us-gaap Assets Current
AssetsCurrent
261611 usd
CY2023Q4 us-gaap Long Term Investments
LongTermInvestments
33114 usd
CY2023Q2 us-gaap Long Term Investments
LongTermInvestments
32604 usd
CY2023Q4 us-gaap Assets
Assets
183177 usd
CY2023Q2 us-gaap Assets
Assets
294215 usd
CY2023Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
618365 usd
CY2023Q2 us-gaap Accounts Payable Current
AccountsPayableCurrent
616245 usd
CY2023Q4 us-gaap Settlement Liabilities Current
SettlementLiabilitiesCurrent
1624775 usd
CY2023Q2 us-gaap Settlement Liabilities Current
SettlementLiabilitiesCurrent
1624775 usd
CY2023Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
2345630 usd
CY2023Q2 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
1485310 usd
CY2023Q4 us-gaap Short Term Bank Loans And Notes Payable
ShortTermBankLoansAndNotesPayable
2259539 usd
CY2023Q2 us-gaap Short Term Bank Loans And Notes Payable
ShortTermBankLoansAndNotesPayable
1164685 usd
CY2023Q4 us-gaap Convertible Notes Payable Current
ConvertibleNotesPayableCurrent
239420 usd
CY2023Q2 us-gaap Convertible Notes Payable Current
ConvertibleNotesPayableCurrent
297805 usd
CY2023Q4 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
1102971 usd
CY2023Q2 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
1079038 usd
CY2023Q4 us-gaap Derivative Liabilities Current
DerivativeLiabilitiesCurrent
238822 usd
CY2023Q2 us-gaap Derivative Liabilities Current
DerivativeLiabilitiesCurrent
1220576 usd
CY2023Q4 us-gaap Liabilities
Liabilities
8729506 usd
CY2023Q2 us-gaap Liabilities
Liabilities
8516217 usd
CY2023Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2023Q2 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2023Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
500000000 shares
CY2023Q2 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
500000000 shares
CY2023Q4 us-gaap Preferred Stock Including Additional Paid In Capital
PreferredStockIncludingAdditionalPaidInCapital
2440 usd
CY2023Q2 us-gaap Preferred Stock Including Additional Paid In Capital
PreferredStockIncludingAdditionalPaidInCapital
2440 usd
CY2023Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2023Q2 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2023Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
60000000000 shares
CY2023Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
43292622779 shares
CY2023Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
43292622779 shares
CY2023Q2 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
60000000000 shares
CY2023Q2 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
39414493 shares
CY2023Q2 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
39414493 shares
CY2023Q4 us-gaap Common Stock Value
CommonStockValue
43292623 usd
CY2023Q2 us-gaap Common Stock Value
CommonStockValue
39414493 usd
CY2023Q4 us-gaap Common Stock Value
CommonStockValue
43292623 usd
CY2023Q2 us-gaap Common Stock Value
CommonStockValue
39414493 usd
CY2023Q4 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
31184749 usd
CY2023Q2 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
32773102 usd
CY2023Q4 PHIL Common Stock To Be Issued
CommonStockToBeIssued
1128388 usd
CY2023Q2 PHIL Common Stock To Be Issued
CommonStockToBeIssued
22500 usd
CY2023Q4 PHIL Common Stock To Be Cancelled
CommonStockToBeCancelled
35500 usd
CY2023Q2 PHIL Common Stock To Be Cancelled
CommonStockToBeCancelled
35500 usd
CY2023Q4 PHIL Treasury Stock Common And Preferred Shares
TreasuryStockCommonAndPreferredShares
484767 shares
CY2023Q2 PHIL Treasury Stock Common And Preferred Shares
TreasuryStockCommonAndPreferredShares
484767 shares
CY2023Q4 us-gaap Treasury Stock Value
TreasuryStockValue
44170 usd
CY2023Q2 us-gaap Treasury Stock Value
TreasuryStockValue
44170 usd
CY2023Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-82021213 usd
CY2023Q2 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-77319372 usd
CY2023Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-2053646 usd
CY2023Q2 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-3035495 usd
CY2023Q4 us-gaap Stockholders Equity
StockholdersEquity
-8546330 usd
CY2023Q2 us-gaap Stockholders Equity
StockholdersEquity
-8222002 usd
CY2023Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
183176 usd
CY2023Q2 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
294215 usd
CY2023Q4 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
5000 usd
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
5000 usd
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
25000 usd
CY2023Q4 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
5000 usd
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
5000 usd
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
25000 usd
CY2023Q4 us-gaap Salaries And Wages
SalariesAndWages
52500 usd
CY2022Q4 us-gaap Salaries And Wages
SalariesAndWages
90000 usd
us-gaap Salaries And Wages
SalariesAndWages
105000 usd
us-gaap Salaries And Wages
SalariesAndWages
180000 usd
CY2023Q4 us-gaap Professional And Contract Services Expense
ProfessionalAndContractServicesExpense
19780 usd
CY2022Q4 us-gaap Professional And Contract Services Expense
ProfessionalAndContractServicesExpense
102537 usd
PHIL Increase Decrease In Accounts Payables
IncreaseDecreaseInAccountsPayables
2120 usd
PHIL Increase Decrease In Accounts Payables
IncreaseDecreaseInAccountsPayables
-4350 usd
us-gaap Professional And Contract Services Expense
ProfessionalAndContractServicesExpense
23735 usd
us-gaap Professional And Contract Services Expense
ProfessionalAndContractServicesExpense
286453 usd
CY2023Q4 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
114412 usd
CY2022Q4 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
22638 usd
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
303688 usd
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
35527 usd
CY2023Q4 us-gaap Operating Expenses
OperatingExpenses
186692 usd
CY2022Q4 us-gaap Operating Expenses
OperatingExpenses
215175 usd
us-gaap Operating Expenses
OperatingExpenses
432423 usd
us-gaap Operating Expenses
OperatingExpenses
501980 usd
CY2023Q4 us-gaap Operating Income Loss
OperatingIncomeLoss
-181692 usd
CY2022Q4 us-gaap Operating Income Loss
OperatingIncomeLoss
-215175 usd
us-gaap Operating Income Loss
OperatingIncomeLoss
-427423 usd
us-gaap Operating Income Loss
OperatingIncomeLoss
-476980 usd
CY2023Q4 us-gaap Interest Expense
InterestExpense
236624 usd
CY2022Q4 us-gaap Interest Expense
InterestExpense
142763 usd
us-gaap Interest Expense
InterestExpense
280300 usd
us-gaap Interest Expense
InterestExpense
445896 usd
CY2023Q4 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-1293622 usd
CY2022Q4 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-259004 usd
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-3994117 usd
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-1515080 usd
CY2023Q4 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-1530246 usd
CY2022Q4 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-401767 usd
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-4274418 usd
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-1960976 usd
CY2023Q4 us-gaap Net Income Loss
NetIncomeLoss
-1711938 usd
CY2022Q4 us-gaap Net Income Loss
NetIncomeLoss
-616942 usd
us-gaap Net Income Loss
NetIncomeLoss
-4701841 usd
us-gaap Net Income Loss
NetIncomeLoss
-2437956 usd
CY2023Q4 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.00
CY2022Q4 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.00
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.00
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.00
CY2023Q4 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.00
CY2022Q4 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.00
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.00
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.00
CY2023Q4 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
42675273063 shares
CY2022Q4 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
33009795067 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
42675273063 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
33009795067 shares
CY2023Q4 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
42675273063 shares
CY2022Q4 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
33009795067 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
42675273063 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
33009795067 shares
us-gaap Net Income Loss
NetIncomeLoss
-4701841 usd
us-gaap Net Income Loss
NetIncomeLoss
-2437956 usd
PHIL Net Change Due To Conversion Of Notes
NetChangeDueToConversionOfNotes
-1936594 usd
PHIL Net Change Due To Conversion Of Notes
NetChangeDueToConversionOfNotes
-1941733 usd
PHIL Cash In Transit
CashInTransit
9500 usd
us-gaap Increase Decrease In Derivative Liabilities
IncreaseDecreaseInDerivativeLiabilities
-613309 usd
us-gaap Derivative Gain Loss On Derivative Net
DerivativeGainLossOnDerivativeNet
415 usd
us-gaap Derivative Gain Loss On Derivative Net
DerivativeGainLossOnDerivativeNet
12 usd
us-gaap Increase Decrease In Deferred Charges
IncreaseDecreaseInDeferredCharges
96433 usd
PHIL Increase Decrease In Accrued Expenses
IncreaseDecreaseInAccruedExpenses
1256133 usd
PHIL Increase Decrease In Accrued Expenses
IncreaseDecreaseInAccruedExpenses
261499 usd
PHIL Increase Decrease In Subfund Obligations And Contingency Commitments
IncreaseDecreaseInSubfundObligationsAndContingencyCommitments
108684 usd
us-gaap Increase Decrease In Contract With Customer Liability
IncreaseDecreaseInContractWithCustomerLiability
-5000 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-1507409 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-835644 usd
us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
474408 usd
PHIL Proceeds From Common Stock To Be Issued
ProceedsFromCommonStockToBeIssued
1105888 usd
PHIL Proceeds From Common Stock To Be Issued
ProceedsFromCommonStockToBeIssued
16000 usd
us-gaap Proceeds From Repayments Of Short Term Debt
ProceedsFromRepaymentsOfShortTermDebt
-63210 usd
us-gaap Proceeds From Repayments Of Short Term Debt
ProceedsFromRepaymentsOfShortTermDebt
770799 usd
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
1517086 usd
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
786799 usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
9677 usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-48845 usd
CY2023Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
19765 usd
CY2022Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
67896 usd
CY2023Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
29442 usd
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
19051 usd
CY2022Q2 us-gaap Stockholders Equity
StockholdersEquity
-6543502 usd
PHIL Stock Issued During Value Conversions Of Promissory Notes
StockIssuedDuringValueConversionsOfPromissoryNotes
233614 usd
PHIL Stock Issued During Value Exercise Of Warrants
StockIssuedDuringValueExerciseOfWarrants
2395080 usd
us-gaap Stock Redeemed Or Called During Period Value
StockRedeemedOrCalledDuringPeriodValue
-545710 usd
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
6881906 usd
CY2023Q1 PHIL Stock Issued During Value Conversions Of Promissory Notes
StockIssuedDuringValueConversionsOfPromissoryNotes
1576175 usd
CY2023Q1 PHIL Stock Issued During Value Conversions Of Promissory Notes
StockIssuedDuringValueConversionsOfPromissoryNotes
1576175 usd
CY2023Q1 PHIL Stock Issued During Value Shares Issued For Cash
StockIssuedDuringValueSharesIssuedForCash
624865 usd
CY2023Q1 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
185000 usd
CY2023Q1 us-gaap Stockholders Equity
StockholdersEquity
-8286628 usd
CY2023Q2 us-gaap Stock Issued During Period Value Conversion Of Units
StockIssuedDuringPeriodValueConversionOfUnits
974877 usd
CY2023Q2 PHIL Stock Issued During Value Shares Issued For Cash
StockIssuedDuringValueSharesIssuedForCash
919396 usd
CY2023Q2 us-gaap Stockholders Equity
StockholdersEquity
-8222002 usd
CY2023Q3 PHIL Stock Issued During Value Conversions Of Promissory Notes1
StockIssuedDuringValueConversionsOfPromissoryNotes1
102937 usd
CY2023Q3 PHIL Stock Issued During Value Exercise Of Warrants1
StockIssuedDuringValueExerciseOfWarrants1
1756320 usd
CY2023Q3 PHIL Stock Issued During Value Conversions Of Promissory Notes2
StockIssuedDuringValueConversionsOfPromissoryNotes2
75016 usd
CY2023Q3 us-gaap Stockholders Equity
StockholdersEquity
-8540992 usd
CY2023Q3 us-gaap Stockholders Equity
StockholdersEquity
-8540992 usd
CY2023Q4 PHIL Stock Issued For Stock Purchase Agreements With Current Shareholders
StockIssuedForStockPurchaseAgreementsWithCurrentShareholders
296004 usd
CY2023Q4 us-gaap Stock Issued During Period Value Conversion Of Units
StockIssuedDuringPeriodValueConversionOfUnits
59500 usd
CY2023Q4 us-gaap Stockholders Equity
StockholdersEquity
-8546330 usd
CY2023Q4 us-gaap Stockholders Equity
StockholdersEquity
-8546330 usd
us-gaap Nature Of Operations
NatureOfOperations
<p id="xdx_808_eus-gaap--NatureOfOperations_zwE7psPac3t8" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span style="text-decoration: underline">NOTE 1</span></b> – <b><span id="xdx_822_zZzncZMoeWxf">NATURE OF BUSINESS</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>INTRODUCTION</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">PHI Group, Inc. (n/k/a Philux Global Group Inc) (the “Company” or “PHI”) (<span style="text-decoration: underline">www.philuxglobal.com</span>) is primarily engaged in mergers and acquisitions, advancing Philux Global Funds, SCA, SICAV-RAIF, a “Reserved Alternative Investment Fund” (“RAIF”) under the laws of Luxembourg, and developing the Asia Diamond Exchange in Vietnam. Besides, the Company provides corporate finance services, including merger and acquisition advisory and consulting services for client companies through our wholly owned subsidiary Philux Capital Advisors, Inc. (formerly PHI Capital Holdings, Inc.) (www.philuxcapital.com<span style="text-decoration: underline">)</span> and invests in selective industries and special situations aiming to potentially create significant long-term value for our shareholders. Philux Global Funds intends to include a number of sub-funds for investment in select growth opportunities in the areas of renewable energy, real estate, infrastructure, healthcare, agriculture, and the Asia Diamond Exchange in conjunction with the International Financial Center in Vietnam.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>BACKGROUND</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Originally incorporated on June 8, 1982 as JR Consulting, Inc., a Nevada corporation, the Company applied for a Certificate of Domestication and filed Articles of Domestication to become a Wyoming corporation on September 20, 2017. In the beginning, the Company was foremost engaged in mergers and acquisitions and had an operating subsidiary, Diva Entertainment, Inc., which operated two modeling agencies, one in New York and one in California. In January 2000, the Company changed its name to Providential Securities, Inc., a Nevada corporation, following a business combination with Providential Securities, Inc., a California-based financial services company. In February 2000, the Company then changed its name to Providential Holdings, Inc. In October 2000, Providential Securities withdrew its securities brokerage membership and ceased its financial services business. Subsequently, in April 2009, the Company changed its name to PHI Group, Inc. From October 2000 to October 2011, the Company and its subsidiaries were engaged in various transactions in connection with mergers and acquisitions advisory and consulting services, real estate and hospitality development, mining, oil and gas, telecommunications, technology, healthcare, private equity, and special situations. In October 2011, the Company discontinued the operations of Providential Vietnam Ltd., Philand Ranch Limited, a United Kingdom corporation (together with its subsidiaries Philand Ranch - Singapore, Philand Corporation - US, and Philand Vietnam Ltd. - Vietnam), PHI Gold Corporation (formerly PHI Mining Corporation, a Nevada corporation), and PHI Energy Corporation (a Nevada corporation), and mainly focused on acquisition and development opportunities in energy and natural resource businesses.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company is currently focused on Philux Global Funds, SCA, SICAV-RAIF by launching Philux Global Select Growth Fund and potentially other sub-funds for investment in real estate, renewable energy, infrastructure, agriculture, healthcare and the International Financial Center and Asia Diamond Exchange in Vietnam. In addition, Philux Capital Advisors, Inc., a wholly owned subsidiary of the Company, continues to provide corporate and project finance services, including merger and acquisition (M&amp;A) advisory and consulting services for U.S. and international companies. The Company has also formed Philux Global Advisors, Inc. to serve as the investment advisor to Philux Global Funds and other potential fund clients in the future.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In May 2023, the company signed a business cooperation agreement with SSE Global JSC, a Vietnamese joint stock company, to establish SSE Global Group, Inc., a Wyoming corporation, (<span style="text-decoration: underline">www.sseglobalgroup.com</span>) to commercialize a self-sustainable energy technology.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In June 2023 the Company signed a business cooperation agreement with Saphia Alkali JSC, a Vietnamese joint stock company, to form Sapphire Alkali Global Group in the United States to finance, manufacture, sell and distribute Saphia Alkali’s proprietary products on a worldwide basis.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In December 2023 the Company signed an Agreement for Comprehensive Cooperation Agreement with a Vietnamese inventor (the “Inventor”) to cooperate in the development and implementation of a proprietary clean energy technology using geomagnetic energy and focus on the following areas: (1) Applying the Inventor’s proprietary inventions that are specifically designed to exploit the earth’s available geomagnetic energy to generate energy and store energy without using an energy storage system (ESS), (2) Producing and providing generators using the earth’s available geomagnetic energy, (3) Producing engines (spaceships, airplanes, ships, cars, trains, motorcycles, etc.) powered by the earth’s available geomagnetic energy, and (4) Developing additional multiple new technologies that the Inventor has studied and researched. The Parties agree to use Philux Global Energy, Inc., a Wyoming corporation and wholly-owned subsidiary of Philux Global Group, Inc., Registration Number 2022-001066221, incorporated on January 3, 2022, as the operating company to commercialize energy-related products based on the proprietary researches and developments of the Inventor. The Inventor shall serve as the Chief Technology Officer of Philux Global Energy, Inc. and transfer certain intellectual properties related to energy generation and energy storage using the earth’s available geomagnetic energy to Philux Global Energy, Inc. to be patented jointly under the name of the Inventor and Philux Global Energy, Inc. for commercialization. The Inventor and the Company each will hold fifty percent (<span id="xdx_900_eus-gaap--EquityMethodInvestmentOwnershipPercentage_iI_dp_uPure_c20231231__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--PhiluxGlobalEnergyIncMember__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_ze3BvjG7mH3g" title="Ownership percentage">50</span>%) of the initial Common Stock of Philux Global Energy, Inc.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company intends to integrate these clean energy technologies in the new subsidiary to be established in United Arab Emirates which will replace its former subsidiary CO2-1-0 (CARBON) Corp. to continue engaging in carbon emission mitigation using blockchain and crypto technologies.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">No assurances can be made that the Company will be successful in achieving its plans.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>BUSINESS STRATEGY</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">PHI’s strategy is to:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1. Identify, build, acquire, commit and deploy valuable resources with distinctive competitive advantages;</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2. Identify, evaluate, acquire, participate and compete in attractive businesses that have large, growing market potential;</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">3. Build an attractive investment that includes points of exit for investors through capital appreciation or spin-offs of business units.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></p>
us-gaap Use Of Estimates
UseOfEstimates
<p id="xdx_842_eus-gaap--UseOfEstimates_zUpx3Ujidyja" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_861_zFwTqMUwA8c5">USE OF ESTIMATES</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The preparation of financial statements in conformity with generally accepted accounting principles requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting periods. Actual results could differ from those estimates.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p>
CY2023Q4 us-gaap Marketable Securities Current
MarketableSecuritiesCurrent
5 usd
us-gaap Concentration Risk Credit Risk
ConcentrationRiskCreditRisk
<p id="xdx_84D_eus-gaap--ConcentrationRiskCreditRisk_zwMKBrDWzecb" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_86A_zlY3OCTFcCxb">RISKS AND UNCERTAINTIES</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In the normal course of business, the Company is subject to certain risks and uncertainties. The Company provides its service and receives marketable securities upon execution of transactions. Consequently, the value of the securities received from customers can be affected by economic fluctuations and each customer’s business growth. The actual realized value of these securities could be significantly different than recorded value.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p>
CY2023Q4 us-gaap Marketable Securities Current
MarketableSecuritiesCurrent
5 usd
CY2023Q4 us-gaap Marketable Securities Current
MarketableSecuritiesCurrent
5 usd
CY2023Q2 us-gaap Marketable Securities Current
MarketableSecuritiesCurrent
420 usd
CY2023Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
500000000 shares
CY2023Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2023Q4 PHIL Treasury Stock Common And Preferred Shares
TreasuryStockCommonAndPreferredShares
484767 shares
CY2023Q4 us-gaap Treasury Stock Value
TreasuryStockValue
44170 usd
CY2023Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
43292622779 shares
CY2023Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
618365 usd
CY2023Q2 us-gaap Accounts Payable Current
AccountsPayableCurrent
616245 usd
CY2023Q4 us-gaap Settlement Liabilities Current
SettlementLiabilitiesCurrent
1624775 usd
CY2023Q2 us-gaap Settlement Liabilities Current
SettlementLiabilitiesCurrent
1624775 usd
CY2023Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
2345630 usd
CY2023Q2 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
1485310 usd
CY2023Q4 us-gaap Short Term Bank Loans And Notes Payable
ShortTermBankLoansAndNotesPayable
2259539 usd
CY2023Q2 us-gaap Short Term Bank Loans And Notes Payable
ShortTermBankLoansAndNotesPayable
1164685 usd
CY2023Q4 us-gaap Convertible Notes Payable Current
ConvertibleNotesPayableCurrent
239420 usd
CY2023Q2 us-gaap Convertible Notes Payable Current
ConvertibleNotesPayableCurrent
297805 usd
CY2023Q4 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
1102971 usd
CY2023Q2 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
1079038 usd
CY2023Q4 us-gaap Derivative Liabilities Current
DerivativeLiabilitiesCurrent
238822 usd
CY2023Q2 us-gaap Derivative Liabilities Current
DerivativeLiabilitiesCurrent
1220576 usd
CY2023Q4 us-gaap Liabilities Current
LiabilitiesCurrent
8729506 usd
CY2023Q2 us-gaap Liabilities Current
LiabilitiesCurrent
8516217 usd
CY2023Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
2345630 usd
CY2023Q4 us-gaap Accrued Salaries Current And Noncurrent
AccruedSalariesCurrentAndNoncurrent
1133094 usd
CY2023Q4 us-gaap Interest Payable Current
InterestPayableCurrent
449059 usd
CY2023Q4 us-gaap Short Term Borrowings
ShortTermBorrowings
2259539 usd
us-gaap Professional Fees
ProfessionalFees
819038 usd
CY2023Q4 us-gaap Deposits
Deposits
260000 usd
CY2023Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
43292622779 shares
CY2015Q1 us-gaap Employee Stock Ownership Plan Esop Number Of Allocated Shares
EmployeeStockOwnershipPlanESOPNumberOfAllocatedShares
1000000 shares
CY2023Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
60000000000 shares
CY2023Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
0.0118 pure
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
P7Y
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
2.393 pure
CY2023Q3 us-gaap Property Management Fee Percent Fee
PropertyManagementFeePercentFee
0.02 pure
CY2023Q3 PHIL Profit From Investment Percentage
ProfitFromInvestmentPercentage
0.30 pure
CY2023Q4 PHIL Common Stock To Be Issued
CommonStockToBeIssued
1128388 usd
CY2023Q4 us-gaap Stockholders Equity
StockholdersEquity
-8546330 usd
CY2023Q4 us-gaap Net Income Loss
NetIncomeLoss
-1711938 usd
CY2022Q4 us-gaap Net Income Loss
NetIncomeLoss
-616942 usd

Files In Submission

Name View Source Status
0001493152-24-009464-index-headers.html Edgar Link pending
0001493152-24-009464-index.html Edgar Link pending
0001493152-24-009464.txt Edgar Link pending
0001493152-24-009464-xbrl.zip Edgar Link pending
ex21-1.htm Edgar Link pending
ex31-1.htm Edgar Link pending
ex31-2.htm Edgar Link pending
ex32-1.htm Edgar Link pending
ex32-2.htm Edgar Link pending
Financial_Report.xlsx Edgar Link pending
form10-q.htm Edgar Link pending
MetaLinks.json Edgar Link pending
phil-20231231.xsd Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
phil-20231231_def.xml Edgar Link unprocessable
phil-20231231_lab.xml Edgar Link unprocessable
form10-q_htm.xml Edgar Link completed
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
phil-20231231_cal.xml Edgar Link unprocessable
phil-20231231_pre.xml Edgar Link unprocessable